New Developments in the Treatment of Advanced Squamous Cell Lung Cancer: Focus on Afatinib

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s104177
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2011English

Spotlight on Afatinib and Its Potential in the Treatment of Squamous Cell Lung Cancer: The Evidence So Far

Therapeutics and Clinical Risk Management
2016English

New Developments in the Management of Non-Small-Cell Lung Cancer, Focus on Rociletinib: What Went Wrong?

OncoTargets and Therapy
OncologyPharmacology
2016English

Developments in the Management of Advanced Non Small Cell Lung Cancer

Journal of Cancer Therapy
2013English

New Advancements and Developments in Treatment of Renal Cell Carcinoma: Focus on Pazopanib

OncoTargets and Therapy
OncologyPharmacology
2010English

Pemetrexed Versus Vinorelbine Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Elderly Patients

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Refining the Treatment of Advanced Nonsmall Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2010English

First-Line Treatment of Metastatic Lung Cancer—New Developments

Oncology & Hematology Review (US)
2008English

Pcn76 - Budget Impact Analysis of Afatinib for the First-Line Treatment of Advanced or Metastatic Non–small-Cell Lung Cancer in China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy